Furthermore, neither VEGF165 nor VEGF165b overexpression alters the in vitro proliferation or apoptosis rates of cells, suggesting that the mechanism of action of VEGF in altering tumour growth rate is not through an autocrine pathway, but likely to be via its known antiangiogenic effects. This evidence concerns the gene VEGFA and neoplasm.